As expected, the augmented TNF‐α, IL‐1β, IL‐6, and p‐p65 expression in the liver tissues of NAFLD mice caused by HFD treatment or in AML‐12 cells challenged with PA were all declined by Asprosin deficiency. The gene discussed is FBN1; the disease is metabolic dysfunction-associated steatotic liver disease.